The HPRA advises healthcare professionals not to retain printed versions of Summary of Product Characteristics (SPC) documents. As these documents are subject to frequent content updates, including changes to safety and dose related information, we recommend that you visit our website as necessary to access the most up-to-date versions. If you have any queries about specific SPCs on our website then please e-mail

Tamsulosin Hydrochloride 400 micrograms Modified-release Capsules, hard

Synthon BVPA0840/013/001

Main Information

Trade NameTamsulosin Hydrochloride 400 micrograms Modified-release Capsules, hard
Active SubstancesTamsulosin hydrochloride
Dosage FormModified-release capsule, hard
Licence HolderSynthon BV
Licence NumberPA0840/013/001

Group Information

ATC CodeG04CA Alpha-adrenoreceptor antagonists
G04CA02 tamsulosin


License statusAuthorised
Licence Issued20/01/2006
Legal statusProduct subject to prescription which may be renewed (B)
Supply StatusSupply through pharmacies only
Advertising StatusAdvertising to healthcare professionals only
Conditions of LicenceAn invented name for this product must be approved by variation prior to marketing this product in Ireland.
Marketing StatusNot marketed


Summary of Product CharacteristicsPDF Version
Package LeafletPDF Version
Public Assessment ReportNo document available

Generics Information

Interchangeable List CodeIC0024-066-044
Interchangeable List DocumentPDF of Interchangeable List
« Back